We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

142 hedge funds and large institutions have $1.14B invested in Immunogen Inc in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 39 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 11

71% more call options, than puts

Call options by funds: $8.3M | Put options by funds: $4.85M

23% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 39

5% more funds holding

Funds holding: 135142 (+7)

3% more capital invested

Capital invested by funds: $1.11B → $1.14B (+$32.6M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
142
Holders Change
+7
Holders Change %
+5.19%
% of All Funds
4.1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
19
Increased
48
Reduced
39
Closed
11
Calls
$8.3M
Puts
$4.85M
Net Calls
+$3.45M
Net Calls Change
+$3.18M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$189M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$182M +$201K +12,723 +0.1%
ClearBridge Investments
3
ClearBridge Investments
New York
$139M +$8.22M +521,129 +6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$78.3M +$3.18M +201,807 +4%
SAM
5
Sectoral Asset Management
Quebec, Canada
$54.1M +$1.74M +110,504 +3%
First Trust Advisors
6
First Trust Advisors
Illinois
$53.9M +$16M +1,013,970 +39%
BFA
7
BlackRock Fund Advisors
California
$47.6M +$1.4M +88,783 +3%
BB
8
BB Biotech
Switzerland
$47.3M -$946K -60,000 -2%
Wellington Management Group
9
Wellington Management Group
Massachusetts
$46.7M -$854K -54,146 -2%
State Street
10
State Street
Massachusetts
$39M +$1.48M +93,879 +4%
BIT
11
BlackRock Institutional Trust
California
$36.9M +$1.93M +122,432 +5%
Norges Bank
12
Norges Bank
Norway
$24M -$12.1M -764,378 -32%
AG
13
Artal Group
Luxembourg
$19.4M -$5.52M -350,000 -21%
Northern Trust
14
Northern Trust
Illinois
$17.3M -$1.07M -67,961 -6%
PA
15
Pinnacle Associates
New York
$13.2M -$591K -37,510 -4%
Invesco
16
Invesco
Georgia
$10.9M +$2.89M +183,032 +33%
Wells Fargo
17
Wells Fargo
California
$10.4M +$729K +46,266 +7%
GIM
18
Granahan Investment Management
Massachusetts
$8.07M -$9.38M -594,760 -52%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$7.17M +$904K +57,322 +14%
Bank of New York Mellon
20
Bank of New York Mellon
New York
$6.51M -$3.31K -210 -0%
Deutsche Bank
21
Deutsche Bank
Germany
$5.42M -$197K -12,502 -3%
TCIM
22
TIAA CREF Investment Management
New York
$5.17M -$78K -4,950 -1%
MAA
23
Managed Account Advisors
New Jersey
$4.86M +$1.14M +72,228 +28%
Morgan Stanley
24
Morgan Stanley
New York
$4.74M -$1.21M -76,497 -19%
Macquarie Group
25
Macquarie Group
Australia
$4M +$3.21M +203,847 +317%

IMGN Hedge Fund Activity: Q1 2014 in Review

142 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2014, worth a combined $1.14B — up 2.9% from $1.11B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IMGN positions and 11 closed out — a net gain of 8 holders — while 48 added to existing stakes and 39 trimmed.

The largest buyer was First Trust Advisors, adding an estimated $16M. The largest seller was Norges Bank, cutting an estimated $12.1M.

  • 142 institutional investors held Immunogen Inc (IMGN) as of Q1 2014, up from 135 in Q4 2013.
  • Funds reported $1.14B of Immunogen Inc stock for Q1 2014, up 2.9% quarter-over-quarter.
  • 19 funds opened new Immunogen Inc positions in Q1 2014 and 11 closed out, a net change of +8 holders.
  • The largest Immunogen Inc buyer in Q1 2014 was First Trust Advisors, an estimated $16M added.
  • The largest Immunogen Inc seller in Q1 2014 was Norges Bank, an estimated $12.1M sold.

Based on aggregated 13F filings for Q1 2014.